A 10-year retrospective cohort analysis of rituximab for the treatment of pemphigus in a Chinese population

J Am Acad Dermatol. 2021 Dec;85(6):1643-1645. doi: 10.1016/j.jaad.2020.12.062. Epub 2021 Jan 7.

¹ Department of Dermatology and Venereology, Peking University First Hospital, the National Clinical Research Center for Skin and Immune Diseases, and the Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, China.
² Department of Dermatology and Venereology, Peking University First Hospital, the National Clinical Research Center for Skin and Immune Diseases, and the Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, China. Electronic address: xixue_chen@163.com.

No abstract available

Publication types